Pharma Mirror
DECEMBER 23, 2024
Have you ever wondered how life-saving treatments for cancer, Alzheimers, or chronic diseases come to life? Clinical trials are the foundation of medical innovation, paving the way for groundbreaking therapies. Yet for many, the idea of joining a trial can feel intimidating or unclear. Experts are here to demystify the clinical trial process, with Dr.
XTalks
DECEMBER 23, 2024
A new Phase IIb clinical trial, ELEVATE IPF, has delivered promising results for deupirfenidone ( LYT-100 ), an investigational drug being evaluated to slow lung function decline in patients with idiopathic pulmonary fibrosis (IPF). The trial involved 257 participants and tested two doses of deupirfenidone over 26 weeks, with participants taking the drug three times a day (TID).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 23, 2024
(Runstudio/Photodisc/Getty Images) If you find yourself sniffling at the merest hint of an irritant, you likely have a different set of microbes calling your nostrils home than everyone else. An international team of researchers has found a unique assortment of fungi up the noses of people who suffer from hayfever and asthma.
FDA Law Blog
DECEMBER 23, 2024
By Mark A. Tobolowsky & Frank J. Sasinowski The Winter Solstice, signifying the shortest day of the year, was Saturday, December 21. Although the earliest sunset of the year was actually in early December, this day also marked another premature sunset the beginning of the end of the rare pediatric disease priority review voucher program. As we blogged recently, the program has had scheduled sunset dates from its very beginning, which have been repeatedly extended.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
pharmaphorum
DECEMBER 24, 2024
The FDA has wrapped up a series of new approvals as 2024 draws to a close, with Novo Nordisk, Pfizer, Vertex, and Hikma among the beneficiaries.
Pharmaceutical Technology
DECEMBER 24, 2024
The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
DECEMBER 23, 2024
The International Day of Epidemic Preparedness, observed annually on December 27 , underscores the necessity of global collaboration to address epidemic threats. Proclaimed by the United Nations (UN) in 2020, this day honors lessons from past crises like COVID-19, emphasizing the importance of readiness in safeguarding lives and economies. A recent World Health Organization (WHO) report revealed a troubling decline in health spending , threatening epidemic resilience by weakening critical system
Medical Xpress
DECEMBER 27, 2024
The rise of antibiotic-resistant bacteria could lead to a catastrophic rise in infection-related deaths, according to new research led by Northern Arizona University.
Pharmaceutical Technology
DECEMBER 23, 2024
Lillys Zepbound has become the first prescription medicine approved to treat adults with moderate to severe obstructive sleep apnoea (OSA) and obesity.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 26, 2024
(Nemes Laszlo/Science Photo Library/Getty Images) How we classify cancer and spot it in its earliest stages could need an urgent rethink: researchers have found that even some healthy women carry cells with the key hallmarks of breast cancer. These cells are known as aneuploid cells, and have an abnormal number of chromosomes.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
XTalks
DECEMBER 27, 2024
Gastro Concepts has achieved a milestone with US Food and Drug Administration (FDA) clearance for its Air Assist device , an innovation designed to transform colonoscopy procedures. By addressing a long-standing challenge in the field air and carbon dioxide (CO 2 ) leakage during colonoscopy Air Assist offers a more efficient and safer approach to maintaining colonic distension.
Medical Xpress
DECEMBER 27, 2024
The ongoing spread of bird flu in the United States has alarmed expertsnot just because of human cases causing severe illness, but also due to troubling new instances of infections in cats.
Pharmaceutical Technology
DECEMBER 24, 2024
XBiotech has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities in its Phase II trial.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 24, 2024
Earlier this year, scientists stumbled upon a potential new treatment for hereditary-patterned baldness, the most common cause of hair loss in both men and women worldwide. It all started with research on a sugar that naturally occurs in the body and helps form DNA: the ‘deoxyribose‘ part of deoxyribonucleic acid.
XTalks
DECEMBER 26, 2024
Menarini Group has announced positive topline data from the Phase III BROADWAY and TANDEM clinical trials, evaluating obicetrapib and the fixed-dose combination of obicetrapib with ezetimibe. These trials aim to address a major challenge in cardiovascular disease: managing elevated low-density lipoprotein cholesterol (LDL-C) levels in patients at risk of heart disease.
Medical Xpress
DECEMBER 27, 2024
A new study from Karolinska Institutet maps the cellular and molecular dynamics of human wound healing in exceptional detail. The study was published in Cell Stem Cell.
Pharmaceutical Technology
DECEMBER 23, 2024
Though still below boom levels seen a few years ago, 2024 compares favourably to 2023, and signs suggest that growth will continue into 2025.
pharmaphorum
DECEMBER 27, 2024
Discover how Generative AI is revolutionising the pharmaceutical industry and moving beyond hype towards widespread adoption in drug discovery and development. Learn more about the impact of GenAI.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Cloudbyz
DECEMBER 22, 2024
Cloudbyz Earns Dual Recognition in Everest Groups 2024 PEAK Matrix for CTMS and EDC Solutions Driving Innovation in Clinical Trial Management Cloudbyz is proud to announce its dual recognition in Everest Groups 2024 PEAK Matrix assessments for both Clinical Trial Management System (CTMS) and Electronic Data Capture (EDC) solutions. This achievement solidifies Cloudbyzs position as a trusted partner in advancing clinical research through cutting-edge, cloud-based technologies.
Medical Xpress
DECEMBER 27, 2024
A study from Tel Aviv University could reshape our scientific understanding of how humans learn and form memories, particularly through classical and operant conditioning.
Pharmaceutical Technology
DECEMBER 23, 2024
Pfizer has gained accelerated approval from the US FDA for BRAFTOVI in conjunction with cetuximab and mFOLFOX6 for treating mCRC.
pharmaphorum
DECEMBER 27, 2024
This article reflects on the current state of diversity in Science, Technology, Engineering, and Mathematics (STEM) fields in 2024 and outlines a path forward for creating a more inclusive and equitable environment.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
JAMA Internal Medicine
DECEMBER 22, 2024
This cross-sectional study using Veterans Affairs data from more than 2 million patient emergency department visits over 8 years examines the variation in physicians admission propensities and how those may relate to mortality outcomes.
Medical Xpress
DECEMBER 27, 2024
A multinational study led by the LHON Study Group has revealed sustained visual improvements and a favorable safety profile five years following lenadogene nolparvovec gene therapy in patients with Leber hereditary optic neuropathy (LHON) caused by the MT-ND4 gene mutation.
Pharmaceutical Technology
DECEMBER 24, 2024
This seed funding comes after GEMMABio secured $100m in October through a partnership with Brazilian supplier Fiocruz.
pharmaphorum
DECEMBER 27, 2024
Explore the concept of being loud in local, regional, and global life sciences with Oliver Stohlmann's Corporate Survival Hacks. Find practical tips and strategies to thrive in the industry.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Commerce
DECEMBER 27, 2024
Check out our top five most engaged social media posts from the year 2024.
Medical Xpress
DECEMBER 27, 2024
UT Southwestern Medical Center researchers have identified a genetic mutation that slows the growth of melanoma and potentially other cancers by harnessing the power of the immune system. Their findings, published in the Journal of Experimental Medicine, could lead to new treatments that improve outcomes from existing cancer immunotherapies.
Pharmaceutical Technology
DECEMBER 24, 2024
RAPT Therapeutics and Shanghai Jemincare Pharmaceutical have signed an exclusive agreement for RPT904 to treat various allergic conditions.
pharmaphorum
DECEMBER 27, 2024
WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum
Expert insights. Personalized for you.
130 
Let's personalize your content